Myoblasts Generated by Lentiviral Mediated MyoD Transduction of Myotonic Dystrophy Type 1 (DM1) Fibroblasts Can Be Used for Assays of Therapeutic Molecules

BMC Research Notes - United Kingdom
doi 10.1186/1756-0500-4-490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Myotonic Dystrophy Type 1

CMAJ
Medicine
2016English

Disease Burden of Myotonic Dystrophy Type 1

Journal of Neurology
Neurology
2019English

Dropped Head Presentation in Myotonic Dystrophy Type 1

Neurology India
Neurology
2005English

Consensus-Based Care Recommendations for Adults With Myotonic Dystrophy Type 1

Neurology: Clinical Practice
Neurology
2018English

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1

Frontiers in Physiology
Physiology
2018English

Recurrent Severe Rhabdomyolysis in a Pregnancy Affected by Myotonic Dystrophy Type 1

Pathology
Forensic MedicinePathology
2020English

Development of Pharmacophore Models for Small Molecules Targeting RNA: Application to the RNA Repeat Expansion in Myotonic Dystrophy Type 1

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

576. A Novel Gene Editing-Based Strategy for Myotonic Dystrophy Type 1

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Dosage Effect of Multiple Genes Accounts for Multisystem Disorder of Myotonic Dystrophy Type 1

Cell Research
Cell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy